Skip to content

FLAMIN-GO

From pathobiology to synovia on chip: driving rheumatoid arthritis to the precision medicine goal

WELCOME

FLAMIN-GO’s Vision

FLAMIN-GO’s VISION is to provide an organ-on-chip solution to open up a new avenue towards personalized care in RA. This solution will be based on the design and fabrication a multi-compartment microfluidic platform, for 3D culturing and perfusion, of all the disease-relevant joint tissues, focusing on synovia and synovial fluid, which are the pathogenetic targeted tissues, but including immune system (vessels and leukocytes) who sustain the disease, as well as cartilage and bone which are the end damaged tissues, leading to permanent disability. The integration with a lab-on-chip and several sensors will allow to monitor continuously culturing conditions and response to drugs.

Rheumatoid Arthritis? Chip it!

News

Flamin-Go Istanbul meeting highlights video

The Third Interim meeting of the project Flamin-Go was a great success, said project coordinator Ann…

3rd Interim meeting of the European project FLAMIN- GO in Istanbul was a success

On April 17th and 18th partners of the European research project FLAMIN-GO met in Istanbul, Turkey a…

FLAMIN-go presented in TV show at the national TV in Slovenia

“Bite the Science” is a weekly show on TV Sloveniaa that explains science in a popular and relaxed w…

Snacks with Scientists

Novara, 24 February 2023 In February, UPO organised an event “Snacks with Scientists” (Ricercatori a…

Workshop on Bioprinting

Interested in bioprinting? Attend the workshop from September 21-23 and learn more: 21st September f…

Personalized

Organ-on-chip, a multi-compartment microfluidic platform offering tailoring and personalized treatment solutions.

Targeted

Focusing on synovia and synovial fluid, which are the pathogenetic targeted tissues, but including immune system who sustain the disease, as well as cartilage and bone

Monitoring

The integration with a lab-on-chip and several sensors will allow to monitor continuously culturing conditions and response to drugs.